Constipation is a very common condition across the world both in adults and children and it impacts the physical and emotional well-being considerably. In adults, the frequency of constipation differs from 2.5% to 79% whereas; in children it is about 0.7% to 29.6%. It has been found that constipation becomes more frequent after the age of 60 years. In addition, people belonging to lower income groups have considerably more frequent constipation than wealthier ones. Constipation occurs less frequently in people with more years of parental education and more frequently in people with high body mass index (BMI) and immobility or less physical activity. Further risk factors for constipation are low-fibre food intake, living in a highly densely populated community, constipation in the family and experiencing anxiety, stressful life events and depression. 

Macrogol has proven to be a safe and effective treatment for constipation for both children and elderly patients. On account of higher water content, the volume of the faecal mass increases which triggers forceful bowel movements via distension of the colonic wall. The increased water content softens the faeces and eases its motion. A relatively low dose of Macrogol helps in improving stool frequency and consistency in patients with chronic constipation. Macrogol continues to be effective in the long term without the need to increase the dosage over time. Although Macrogol is not associated with severe side effects, it may cause diarrhea and bloating Macrogol does not alter the normal structure of the surface of the bowel. 

The report titled “Global macrogol laxatives market- Growth, Future Prospects and Competitive Analysis, 2024 – 2032” provides in-depth analysis into the global macrogol laxatives market in addition to market size and estimates for the period from 2024 to 2032. Macrogol market is expected to grow at a steady rate with a CAGR of 4.6% during the forecast period from 2024 to 2032. The research study provides strategic insights on various market segments based on drug name, disease, age group and cross-sectional analysis for different geographic regions. The report offers a comparative analysis of various segments for the years 2024 and 2032.

In order to help decision-makers, the report covers competitive profiling of the leading manufacturers of macrogol laxatives, competitive landscape and key market developments. Some of the major players included in the report are Ipsen Group, Norgine B.V., RECORDATI S.p.A., Tillotts Pharma AG, Stirling Anglian Pharmaceuticals, Meda AS, Dr. Falk Pharma GmbH, Fresenius Kabi Australia Pty Limited, Galen Limited, and Bayer Health Care LLC. 

Other detailed analysis covered in the report includes:

• Current and future market trends to point out attractive investment areas within the macrogol laxatives industry
• Market drivers, market restraints, and their impact on the market estimations
• In-depth competitive analysis
• 2-year historic market size data (2020 – 2021)

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Macrogol Laxatives market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Macrogol Laxatives market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Macrogol Laxatives market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Macrogol Laxatives market?
• Which is the largest regional market for Macrogol Laxatives market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Macrogol Laxatives market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Macrogol Laxatives market worldwide?